Tag - covid-19-vaccines

 
 

COVID 19 VACCINES

Japan Times
WORLD / Science & Health
Sep 18, 2020
COVID-19 vaccine leaders make trial plans public in transparency push
The moves come amid increasing concern that the effort to develop a COVID-19 vaccine is becoming politicized.
Japan Times
ASIA PACIFIC / Science & Health / FOCUS
Sep 16, 2020
In coronavirus vaccine race, China inoculates thousands before trials are completed
Beijing has engaged a public, top-down approach to endorse the experimental vaccines and foster community support.
Japan Times
WORLD / Science & Health
Sep 16, 2020
Pfizer COVID-19 vaccine trial reports no major safety issues
Safety has been a paramount concern since AstraZeneca paused tests of the vaccine it's co-developing with the University of Oxford following an adverse event in a U.K.
Japan Times
WORLD / Science & Health
Sep 11, 2020
China starts testing coronavirus nasal spray vaccine
Some scientists hope a vaccine that gets sprayed through the nose may have a better chance of stopping the spread of the insidious virus through respiratory tracts.
Japan Times
WORLD
Sep 6, 2020
Race for coronavirus vaccine pits spy against spy
The pandemic has prompted one of the fastest peacetime mission shifts in recent times for the world's intelligence agencies, pitting them against one another.
Japan Times
WORLD / Science & Health
Sep 3, 2020
COVID-19 vaccine front-runners will soon see their moment of truth
Early safety data is key; unlike drugs, vaccines are typically given to relatively healthy people and shouldn't create severe risks.
Japan Times
ASIA PACIFIC / Science & Health
Sep 2, 2020
Vaccine front-runner held back by China’s spat with Canada
One of the world’s fastest-moving efforts to develop a COVID-19 vaccine is falling behind rivals, its advance appearing to be stymied by political tensions between China and Canada and concerns its shot may not work as well as others.
Japan Times
WORLD / Science & Health / FOCUS
Aug 31, 2020
Scientists see downsides to top COVID-19 vaccines from Russia and China
High-profile COVID-19 vaccines developed in Russia and China share a potential shortcoming: They are based on a common cold virus that many people have been exposed to, potentially limiting their effectiveness, some experts say.
JAPAN / Science & Health
Aug 31, 2020
Daiichi Sankyo's COVID-19 vaccine candidate selected by Japanese drug discovery body
Daiichi Sankyo Co. said on Monday that its mRNA-based COVID-19 vaccine candidate was selected for inclusion in a drug discovery program by the Japan Agency for Medical Research and Development.
Japan Times
WORLD / Science & Health
Aug 29, 2020
First U.S. novel coronavirus reinfection case identified in Nevada study
Researchers for the first time have identified someone in the United States who was reinfected with the novel coronavirus, according to a study that has not yet been reviewed by outside experts.
Japan Times
JAPAN / Society
Aug 28, 2020
Abe vows COVID-19 vaccinations for all Japan citizens by mid-2021
In view of the coming flu season, test kits will be provided at a volume that will allow for an average of 200,000 tests to be conducted every day.
Japan Times
BUSINESS / Economy
Aug 27, 2020
Coronavirus vaccine could spark Japan recovery by 2022, economist says
Columbia University professor Takatoshi Ito says data is already signaling that Japan is bouncing back.
Japan Times
WORLD / Science & Health / FOCUS
Aug 26, 2020
Developing countries don’t want to wait for superpowers’ vaccines
After COVID-19’s emergence in Buenos Aires led to a strict lockdown in March, Juliana Cassataro and her fellow vaccine researchers grew concerned. The U.S., Europe and China had already revved up their quests to obtain shots; how far back in line would Argentina have to wait for supplies?
Japan Times
WORLD / Science & Health
Aug 22, 2020
New antibody tests offer better snapshot of COVID-19 immunity
A new crop of COVID-19 antibody tests measures the level of protection someone has built up against the deadly virus and may help determine which vaccines are most effective.
Japan Times
WORLD / Science & Health
Aug 16, 2020
Coronavirus crisis has made Brazil an ideal vaccine laboratory
With a medical manufacturing infrastructure and plenty of vaccine trial volunteers, Brazil has emerged as a potentially vital player in the scramble to end the pandemic.
Japan Times
JAPAN / Science & Health
Aug 14, 2020
Coronavirus antibodies disappear in months. Is that a cause for concern?
Research has poured cold water on the optimism of those who have been working around the clock to produce vaccines against the disease.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?